Efficacy and Safety of Heated Chinese Herb Medicine Patch Therapy on Chemotherapy-Induced Aplastic Anemia
The objective of this clinical trial is to establish a treatment for chemotherapy-induced pancytopenia symptoms using heated traditional Chinese medicine (TCM) plasters through a randomized, single-blind clinical trial.
The primary question it aims to answer is whether heated TCM plasters improve chemotherapy-induced pancytopenia symptoms, maintain or increase white blood cells, platelets, and red blood cells, reduce the use of G-CSF and blood transfusions, and enhance cancer patients' quality of life. It also aims to assess if there are any adverse patient reactions to this treatment.
The researchers will compare heated TCM plasters with placebo heated/plaster, placebo TCM plasters, and placebo heated TCM plasters to determine whether the treatment improves chemotherapy-induced pancytopenia symptoms.
Participants will apply the plaster for 1 hour, once daily, 6 days a week for 2 consecutive weeks, totaling 12 applications. Full blood tests (Complete Blood Count, CBC) and white blood cell differential count (DC) will be performed before and after the treatment, and participants will complete the FACT-G cancer treatment-related quality of life scale.
研究概览
地位
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Taiping District
-
Taichung、Taiping District、台湾、411228
- Taichung armed forces gereral hospital
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
Patients were eligible if they were:
(i) had a diagnosis of stage I-IV cancer. (ii) be aged 20 years or older. (iii)hematological dysfunction: have experienced a WBC count of <4000/μL or ANC <1500/μL after starting chemotherapy.
(iv) can understand and voluntarily sign the informed consent form t
Exclusion Criteria:
The following conditions disqualify participants from the study:
(i) Patients who are unsuitable for moxibustion, including those with wounds at the moxibustion site.
(ii)Individuals who refuse to sign the informed consent form. (iii) Minors, pregnant women, individuals with mental illnesses, those at risk of harm, or vulnerable groups.
(iv)Leukemia patients, as the disease itself affects blood cell changes. (v) Those who have used leukopoietic agents or received blood transfusions within the past month.
学习计划
研究是如何设计的？
设计细节
- 主要用途：支持治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
假比较器：Control group (sham heated TCM plaster group)
No heat source, no TCM plaster group
|
The same acupuncture points and frequency are used, but instead of the medicinal cake, 5g of flour colored with caramel dye is applied.
An unlit moxa column is placed in a moxibustion box to serve as a placebo heat source.
|
|
实验性的：Experimental group (Heated TCM plaster group)
Heat source + TCM plaster group
|
Each time, 5g of the medicinal powder is combined with 7g of tap water and applied to gauze to form a medicinal cake.
The researcher then places it on the Shenque point (International acupuncture point code: RN8).
Additionally, a 3g moxa column with a 80:1 moxa wool ratio is ignited and placed in a moxibustion box to generate heat, which is layered over the medicinal cake for 1 hour.
The treatment is applied once a day, 6 days a week, for 2 consecutive weeks, totaling 12 sessions.
|
|
安慰剂比较：Heat source without TCM plaster group
heat source, no TCM plaster group
|
Only 3g of moxa wool (80:1 ratio) is ignited and placed in a moxibustion box to generate heat.
The researcher directly applies it to the Shenque point for 1 hour, once a day, 6 days a week for 2 consecutive weeks, totaling 12 sessions.
(If the participant feels it's too hot, they can either move the moxa wool around the Shenque point themselves or ask the researcher to do so to avoid burns.)
|
|
安慰剂比较：No heat source with TCM plaster group
no heat source, but TCM plaster group
|
Only a TCM medicinal cake is applied to the Shenque point, with no heat source or moxibustion box used.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Number of participants with abnormal blood tests results
大体时间：Before the intervention (baseline, Day 1) and within 3 days after completion of the 12 intervention sessions(2 weeks).
|
A complete blood count (CBC) and differential count (DC) will be performed by the hospital's Department of Laboratory Medicine.
A 3 mL blood sample will be collected before and after the intervention, for a total of two blood draws.
The test items are as follows:
|
Before the intervention (baseline, Day 1) and within 3 days after completion of the 12 intervention sessions(2 weeks).
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
"Traditional Chinese Medicine Constitution Questionnaire"
大体时间：Before the intervention (baseline, Day 1)
|
Before the intervention (baseline, Day 1)
|
|
|
"FACT-G Quality of Life Questionnaire for Cancer Patients (Version 4)"
大体时间：Before the intervention (baseline, Day 1) and after completion of the 12 intervention sessions (2 weeks)
|
The Functional Assessment of Cancer Therapy-General Questionnaire(FACT-G)comprises 27 questions that assess four primary dimensions of QOL: physical (PWB; 7 items), social and family (SFWB; 7 items), emotional (EWB; 6 items), and functional well-being (FWB; 7 items).
It uses 5-point Likert-type response categories ranging from 0 = 'not at all' to 4 = 'very much'.
The total FACT-G score is the summation of the 4 subscale scores and ranges from 0 to 108.
The higher scores in FACT-G mean a better or worse outcome.
|
Before the intervention (baseline, Day 1) and after completion of the 12 intervention sessions (2 weeks)
|
|
the number of G-CSF
大体时间：the number of G-CSF used during the 12 intervention sessions period (at the end of this cycle, the cycle is 14 days).
|
the number of G-CSF used during the 12 intervention sessions period (at the end of this cycle, the cycle is 14 days).
|
|
|
the number of blood transfusions
大体时间：the number of blood transfusions used during the 12 intervention sessions period (at the end of this cycle, the cycle is 14 days).
|
the number of blood transfusions used during the 12 intervention sessions period (at the end of this cycle, the cycle is 14 days).
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.